Copy Link Print Information

Brolucizumab

(Synonyms: DLX1008; ESBA 1008; RTH258)
Customer Review

Based on 1 Customer Validation

Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer.

For research use only. We do not sell to patients.

  • Purity: 99.90%
  • CAS No.: 1531589-13-5
  • Molecular Weight:26.18 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Brolucizumab
  • Experimental Validation Results for Brolucizumab
  • Experimental Validation Results for Brolucizumab
  • Brolucizumab Chemical Structure
    Brolucizumab Chemical Structure
CAS No.: 1531589-13-5
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Brolucizumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

All VEGFR Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    scFv-kappa-heavy

  • 1/16

    Immobilized VEGF165 Protein, Human can bind Brolucizumab. The EC50 for this effect is 102.2 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 Hela cells with Brolucizumab (HY-P9973, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG2 kappa (HY-P99002, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Brolucizumab Chemical Structure
    1/16
  • Brolucizumab
  • Immobilized VEGF165 Protein, Human can bind Brolucizumab. The EC50 for this effect is 102.2 ng/mL.
  • Flow cytometric analysis of 1X106 Hela cells with Brolucizumab (HY-P9973, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG2 kappa (HY-P99002, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • scFv-kappa-heavy